Compare TLPH & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLPH | EEA |
|---|---|---|
| Founded | 2005 | 1986 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.3M | 73.5M |
| IPO Year | 2010 | N/A |
| Metric | TLPH | EEA |
|---|---|---|
| Price | $1.19 | $11.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 301.1K | 10.7K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.92% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,151,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.50 | $9.62 |
| 52 Week High | $1.57 | $11.43 |
| Indicator | TLPH | EEA |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 56.23 |
| Support Level | $0.74 | $10.70 |
| Resistance Level | $1.48 | $11.26 |
| Average True Range (ATR) | 0.08 | 0.12 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 21.79 | 73.97 |
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.